Comparison of Bone Marrow Stromal Cells Derived From Stroke and Normal Rats for Stroke Treatment
Year: 2010
Type: article
Abstract: BACKGROUND AND PURPOSE: We compared the effect of treatment of stroke with bone marrow stromal cells from stroke rats (Isch-BMSC) and normal rats (Nor-BMSC) on functional outcome. METHODS: Isch-BMSCs and Nor-BMSCs were intravenously injected into rats 24 hours after middle cerebral artery occlusion. To test the mechanism of Isch-BMSC-enhanced neurorestoration, Isch-BMSC and Nor-BMSC cultures were used. RESULTS: Isch-BMSC significantly promoted functional outcome and enhanced angiogenesis, arterial density, and axonal regeneration compared with Nor-BMSC treatment animals. Isch-BMSCs exhibited increased Angiopoietin-1, Tie2, basic fibroblast growth factor, glial cell-derived neurotrophic factor, vascular endothelial growth factor, and Flk1 gene expression compared with Nor-BMSC. Using transwell coculture of BMSCs with brain-derived endothelial cells, Isch-BMSCs increased phosphorylated-Tie2 activity in brain-derived endothelial cells and enhanced brain-derived endothelial cells capillary tube formation compared with Nor-BMSCs. Inhibition of Tie2 gene expression in brain-derived endothelial cells using siRNA significantly attenuated BMSC-induced capillary tube formation. CONCLUSIONS: These data suggest that Isch-BMSCs are superior to Nor-BMSCs for the neurorestorative treatment of stroke, which may be mediated by the enhanced trophic factor and angiogenic characteristics of Isch-BMSCs.
Source: Stroke
Institutions: Henry Ford Health, Henry Ford Hospital, Oakland University
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Keywords: mesenchymal stem cells, ischemic stroke, cell therapy, neurorestoration, angiogenesis, Tie2, angiopoietin-1, vascular endothelial growth factor, basic fibroblast growth factor, glial cell line-derived neurotrophic factor, axon regeneration, capillary tube formation, middle cerebral artery occlusion
Open Access status: bronze
OpenAlex ID: W2055028330
